UTHR insider trading: UNITED THERAPEUTICS Corp insider buys & sells · Whale Atlas

UTHR

Nasdaq

UNITED THERAPEUTICS Corp

Latest disclosureOctober 7, 2026

Insider score Why 0?: 0/ 100
Qualifying buys · 30d: $0

1 purchases · 1919 sales

Price by TradingView

Insider transactions 2332

Limited filing history

Filters

Last 30 daysNo qualifying insider buying. Sales: $114.49M by 3 insiders.

Showing the first 6 of 20 trades on this page.

Exercise or conversion

Martine A. Rothblatt

Chairperson & CEO

Common Stock

Value context: $1.12M
Reported price: $117.76 / share

Sale disclosed

Martine A. Rothblatt

Chairperson & CEO

Common Stock

Reported value: $147.81K
Reported price

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Source: SEC EDGAR · Form 4
Issuer CIK: 0001082554
Latest public acceptance: Oct 7, 2026, 08:35 PM UTC
Score calculated: Oct 8, 2026, 12:05 AM UTC
Parser: form4-parser-1.5
Classifier: form4-classifier-1.1
Scoring methodology: insider-experimental-1.1
Availability: Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.

Sale disclosed

Martine A. Rothblatt

Chairperson & CEO

Common Stock

Reported value: $89.23K
Reported price: $534.3018 / share

Sale disclosed

Martine A. Rothblatt

Chairperson & CEO

Common Stock

Reported value: $393.21K
Reported price: $535.7087 / share

Sale disclosed

Martine A. Rothblatt

Chairperson & CEO

Common Stock

Reported value: $173.21K
Reported price: $536.2515 / share

Sale disclosed

Martine A. Rothblatt

Chairperson & CEO

Common Stock

Reported value: $71.5K
Reported price: $537.5758 / share

Sale disclosed

Martine A. Rothblatt

Chairperson & CEO

Common Stock

Reported value: $586.01K
Reported price: $538.6083 / share

Sale disclosed

Martine A. Rothblatt

Chairperson & CEO

Common Stock

Reported value: $866.72K
Reported price: $539.6752 / share

Sale disclosed

Martine A. Rothblatt

Chairperson & CEO

Common Stock

Reported value: $1.11M
Reported price: $540.6783 / share

Sale disclosed

Martine A. Rothblatt

Chairperson & CEO

Common Stock

Reported value: $205.79K
Reported price: $541.5549 / share

Sale disclosed

Martine A. Rothblatt

Chairperson & CEO

Common Stock

Reported value: $65.1K
Reported price: $542.4903 / share

Sale disclosed

Martine A. Rothblatt

Chairperson & CEO

Common Stock

Reported value: $303.55K
Reported price: $543.9937 / share

Sale disclosed

Martine A. Rothblatt

Chairperson & CEO

Common Stock

Reported value: $458.68K
Reported price: $544.752 / share

Sale disclosed

Martine A. Rothblatt

Chairperson & CEO

Common Stock

Reported value: $43.64K
Reported price: $545.495 / share

Exercise or conversion

Martine A. Rothblatt

Chairperson & CEO

Stock Option

Derivative security · not the ordinary share price.

Value context: Not a separate purchase
Exercise / conversion price: $117.76 exercise / conversion price

Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Exercise or conversion

Martine A. Rothblatt

Chairperson & CEO

Common Stock

Value context: $1.12M
Reported price: $117.76 / share

Reporting insider	Security / transaction	Amount / price	Value	Traded / disclosed	Source
Chairperson & CEO	Common StockOption exercise or conversion10b5-1	9,500$117.76 / share	$1.12M	Oct 6Filed Oct 7 · 1d later	SEC filing
Chairperson & CEO	Common StockSale10b5-117 trades	9,500avg $538.67 / share	$5.12M	Oct 6Filed Oct 7 · 1d later	17 filings 280 @ $527.90 · $147.81KSEC filing 360 @ $528.72 · $190.34KSEC filing 240 @ $530.13 · $127.23KSEC filing 320 @ $531.94 · $170.22KSEC filing 215 @ $533.14 · $114.63KSEC filing 167 @ $534.30 · $89.23KSEC filing 734 @ $535.71 · $393.21KSEC filing 323 @ $536.25 · $173.21KSEC filing 133 @ $537.58 · $71.5KSEC filing 1,088 @ $538.61 · $586.01KSEC filing 1,606 @ $539.68 · $866.72KSEC filing 2,054 @ $540.68 · $1.11MSEC filing 380 @ $541.55 · $205.79KSEC filing 120 @ $542.49 · $65.1KSEC filing 558 @ $543.99 · $303.55KSEC filing 842 @ $544.75 · $458.68KSEC filing 80 @ $545.50 · $43.64KSEC filing
Chairperson & CEO	Stock OptionOption exercise or conversion10b5-1	Derivative units9,500$117.76 exercise / conversion price	Not a separate purchase	Oct 6Filed Oct 7 · 1d later	SEC filing
Chairperson & CEO	Common StockOption exercise or conversion10b5-1	9,500$117.76 / share	$1.12M	Oct 5Filed Oct 6 · 1d later	SEC filing

1 purchases · 1919 sales

Insider transactions 2332

Martine A. Rothblatt

Martine A. Rothblatt

Why this buying score?

No qualifying common-equity purchases

Sources and coverage

Martine A. Rothblatt

Martine A. Rothblatt

Martine A. Rothblatt

Martine A. Rothblatt

Martine A. Rothblatt

Martine A. Rothblatt

Martine A. Rothblatt

Martine A. Rothblatt

Martine A. Rothblatt

Martine A. Rothblatt

Martine A. Rothblatt

Martine A. Rothblatt

Martine A. Rothblatt

Martine A. Rothblatt

Martine A. Rothblatt

Martine A. Rothblatt

Martine A. Rothblatt

Martine A. Rothblatt

Congress transactions 3